Small Molecule mRNA Biology Modulators

Anima Biotech is transforming target and drug discovery with a unique Visual Biology approach, with pipeline of small molecule mRNA biology modulators, addressing hard-to-drug areas traditional approaches can't reach:

  • Immunology: Lung fibrosis candidate advancing in preclinical stage.
  • Oncology: Solid tumor lead compounds entering preclinical stage, with additional programs targeting Lymphoma and Neuroblastoma.
  • Neuroscience: Alzheimer's disease and Pain management.

With 20+ programs advancing across our internal pipeline and partnerships with AbbVie, Takeda, and Lilly, we are actively exploring new collaborations. Let’s partner: [email protected]

Indication   Target
Discovery
Optimization
Preclinical
Immunology
Lung fibrosis   1
Multiple fibrosis 2
Multiple fibrosis 3
Undisclosed abbvie logo 4
Oncology
Solid tumors   5
Solid tumors 6
Leukemia 7
Neuroblastoma   8
Solid tumors   9
Undisclosed abbvie logo 10
Undisclosed 11
Neuroscience
Alzheimer   12
Pain   13
Undisclosed 14
Undisclosed takeda logo 15
Undisclosed 16
Huntington   17
Undisclosed lilly logo 18
Undisclosed 19
Undisclosed 20
Area Indication Target
Discovery
Optimization
Preclinical
Immunology Lung fibrosis 1
Multiple fibrosis 2
Multiple fibrosis 3
Undisclosed abbvie logo 4
Oncology Solid tumors 5
Solid tumors 6
Leukemia 7
Neuroblastoma 8
Solid tumors 9
Undisclosed abbvie logo 10
Undisclosed 11
Neuroscience Alzheimer   12
Pain   13
Undisclosed   14
Undisclosed takeda logo 15
Undisclosed 16
Huntington   17
Undisclosed lilly logo 18
Undisclosed 19
Undisclosed 20